Search Ontology:
ChEBI
pexidartinib
- Term ID
- CHEBI:145373
- Synonyms
-
- 5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-{[6-(trifluoromethyl)pyridin-3-yl]methyl}pyridin-2-amine
- CML-261
- pexidartinib
- pexidartinibum
- PLX-3397
- PLX3397
- Turalio
- Definition
- A pyrrolopyridine that is 5-chloro-1H-pyrrolo[2,3-b]pyridine which is substituted by a [6-({[6-(trifluoromethyl)pyridin-3-yl]methyl}amino)pyridin-3-yl]methyl group at position 3. It is a potent multi-targeted receptor tyrosine kinase inhibitor of CSF-1R, KIT, and FLT3 (IC50 of 20 nM, 10 nM and 160 nM, respectively). Approved by the FDA for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT).
- References
-
- CAS:1029044-16-3
- DrugBank:DB12978
- KEGG:D11270
- PDBeChem:P31
- PMCID:PMC6012252
- PMID:26222558
- PMID:26449250
- PMID:30002809
- PMID:30628737
- PMID:30825104
- PMID:30926949
- PMID:31167689
- PMID:31213500
- PMID:31229240
- PMID:31240240
- PMID:31258629
- PMID:31602563
- PMID:31696640
- Wikipedia:Pexidartinib
- Ontology
- ChEBI ( EBI )
- is a type of
-
- has_role
-
Phenotype
Phenotype resulting from pexidartinib
Phenotype where environments contain pexidartinib
Phenotype modified by environments containing pexidartinib
Human Disease Model